Universität Leipzig
Welcome,         Profile    Billing    Logout  
 18 Trials 
38 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Scheinert, Dierk
NCT02701543: Compare I Pilot Study for the Treatment of Subjects With Symptomatic Femoropopliteal Artery Disease

Completed
N/A
414
Europe
Ranger Drug Eluting Balloon, In Pact Drug Eluting Balloon
University of Leipzig
Peripheral Artery Disease
10/18
12/23
ACST-2, NCT00883402: Carotid Endarterectomy Versus Carotid Artery Stenting in Asymptomatic Patients

Active, not recruiting
N/A
3638
Europe, Canada, Japan, US, RoW
CEA, CAS
University of Oxford, NHS Health Technology Assessment Programme, BUPA Foundation, British Heart Foundation
Carotid Stenosis
12/20
12/25
NCT03776799: BEST SFA Pilot Study - Best Endovascular STrategy for Complex Lesions of the Superficial Femoral Artery

Active, not recruiting
N/A
120
Europe
Stent-avoiding, Stent-based
University of Leipzig
Peripheral Arterial Disease
08/22
07/26
NCT03751527: ZENFlex-Registry to Evaluate the Outcome of Bare Metal Stent-assisted Angioplasty

Recruiting
N/A
200
Europe
ZENFLEX peripheral stent system
Zhejiang Zylox Medical Device Co., Ltd.
Atherosclerosis of Femoral Artery
12/22
12/23
NCT04299906: SOLARIS Peripheral PMCF Trial

Active, not recruiting
N/A
70
Europe
Solaris Vascular Stent Graft
Dr. Sabrina Overhagen, FCRE (Foundation for Cardiovascular Research and Education), Scitech Produtos Medicos Ltda
Peripheral Arterial Disease, Iliac Artery Stenosis, Common Femoral Artery Stenosis
11/24
12/24
NCT05132361: SELUTION4SFA Trial

Recruiting
N/A
300
Europe, US, RoW
SELUTION SLR™ 018 DEB, Plain (Uncoated) Balloon Angioplasty (PTA)
MedAlliance, LLC, NAMSA, Cordis Corporation
Peripheral Arterial Disease, Superficial Femoral Artery Stenosis
08/25
12/29
STRIDE II, NCT06747117: A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System

Not yet recruiting
N/A
300
NA
Indigo Aspiration System
Penumbra Inc.
Lower Extremity Acute Limb Ischemia, LE ALI
06/28
01/29
SOCRATES, NCT04503395: ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR:

Recruiting
N/A
204
Europe
ESAR treatment: Endograft + Heli-FX Endoanchor, FEVAR treatment : Fenestrated endograft
FCRE (Foundation for Cardiovascular Research and Education), Medtronic
Aortic Aneurysm, Abdominal
06/26
06/28
CRACK-IT, NCT06112171: Comparison of a Lithotripsy vs Standard Preparation Followed by Stenting With Supera Stent in Femoropopliteal Lesions

Recruiting
N/A
120
Europe
Intravascular lithotripsy, Standard lesion preparation
University of Leipzig
Peripheral Arterial Disease
11/26
12/30
LIMES, NCT04772300: Trial to Assess the Safety and Efficacy of Sirolimus-Coated Balloon vs. Uncoated Standard Angioplasty for the Treatment of Below-the-knee Peripheral Arterial Disease

Recruiting
N/A
230
Europe
Percutaneous Transluminal Angioplasty (PTA) MagicTouch Sirolimus Coated PTA Balloon Catheter, Percutaneous Transluminal Angioplasty (PTA) with non-coated balloon catheter (POBA)
Jena University Hospital, Concept Medical Inc., Vascuscience, CoreLab Black Forest, Center for Clinical Studies, University Hospital Jena
Peripheral Artery Disease
12/27
09/28
Exner, Cornelia
RELATE, NCT04578314: - Efficacy and Feasibility of a Cognitive Behavioural Module for Distressing Auditory Verbal Hallucinations

Completed
N/A
85
Europe
Relating Therapy, Treatment as usual
University of Hamburg-Eppendorf, University of Leipzig, Universitätsklinikum Hamburg-Eppendorf, Jacobs University Bremen gGmbH, Charite University, Berlin, Germany
Verbal Auditory Hallucination, Psychotic Disorders, Psychosis, Schizophrenia
04/22
01/23
Franke, Georg-Nikolaus
IDUNN, NCT04629833 / 2019-001462-15: Treatment of Steroid-Refractory Acute Graft-versus-host Disease with Mesenchymal Stromal Cells Versus Best Available Therapy

Recruiting
3
210
Europe
MC0518, BAT
medac GmbH
Steroid-refractory Acute Graft-versus-host Disease
08/27
08/30
OASIS, NCT05101187: Olorofim Aspergillus Infection Study

Recruiting
3
225
Europe, Canada, Japan, US, RoW
Olorofim, Olorofim (F901318), AmBisome®, AmBisome® (liposomal amphotericin B)
F2G Biotech GmbH, Iqvia Pty Ltd, Shionogi
Invasive Aspergillosis
09/25
11/26
MO-TRANS, NCT05429632 / 2021-002864-36: Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

Active, not recruiting
3
249
Europe, Japan, US, RoW
mocravimod
Priothera SAS, Priothera S.A.S.
Adult Acute Myeloid Leukemia
11/25
11/25
AlloRelapseMM, NCT05675319: Allogeneic Stem Cell Transplantation vs. Conventional Therapy as Salvage Therapy for Relapsed / Progressive Patients With Multiple Myeloma After First-line Therapy

Recruiting
3
482
Europe
Allogeneic Stem Cells, carfilzomib/lenalidomide/dexamethasone (KRD), elotuzumab/lenalidomide/dexamethasone (ERD), daratumumab/bortezomib/dexamethasone (DVD), daratumumab/lenalidomide/dexamethasone (DRD), ixazomib/lenalidomide/dexamethasone (IRD), pomalidomide/bortezomib/dexamethasone (PVD), carfilzomib/daratumumab/dexamethasone (KDD), Autologous Stem Cells, daratumumab/pomalidomide/dexamethasone (DPD), isatuximab/carfilzomib/dexamethasone (Isa-KD), selinexor/bortezomib/dexamethasone (SVD)
Universitätsklinikum Hamburg-Eppendorf, Gemeinsamer Bundesausschuss (G-BA), Staburo GmbH
Multiple Myeloma
03/28
03/33
NCT04232241: Matched Unrelated vs. Haploidentical Donor for Allogeneic Stem Cell Transplantation in Patients With Acute Leukemia

Recruiting
2
440
Europe, RoW
Allogeneic Stem Cell Transplantation
Universitätsklinikum Hamburg-Eppendorf, DKMS Stiftung Leben Spenden, Clinical Trial Center North (CTC North GmbH & Co. KG)
Acute Myeloid Leukemia in Remission, Acute Lymphoblastic Leukemia in Remission, Myelodysplastic Syndromes
11/22
11/24
MYLOX-1, NCT04679870 / 2020-003087-45: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral GB2064 in Participants With Myelofibrosis

Active, not recruiting
2
21
Europe, US, RoW
GB2064
Galecto Biotech AB, OPIS s.r.l
Myelofibrosis
12/23
06/26
BlastCrisis, NCT03869502: European CML Blast Crisis Register

Recruiting
N/A
250
Europe, RoW
University of Jena
Chronic Myeloid Leukemia in Myeloid Blast Crisis
06/24
06/24
TAK-620-5010, NCT06615921: A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection

Recruiting
N/A
150
Europe, RoW
No Intervention
Takeda
Cytomegalovirus (CMV)
04/25
04/25
Schmidt, Andrej
NCT04799769: Safety and Performance Study of Large Hole Vascular Closure Device - FRONTIER V Study

Recruiting
N/A
90
Europe
Percutaneous arterial closure device
Vivasure Medical Limited
Percutaneous Arteriotomy Closure
01/23
03/23
HEAL, NCT04110327: An All-Comers Observational Study of the MicroStent™ Peripheral Vascular Stent System in Subjects with Peripheral Arterial Disease

Recruiting
N/A
300
Europe
MicroStent
Micro Medical Solution, Inc.
Peripheral Arterial Disease, Critical Lower Limb Ischemia
12/26
12/28
NCT05406622: MOTIV BTK Randomized Controlled Trial

Recruiting
N/A
292
Europe, US
MOTIV Sirolimus-Eluting Bioresorbable Scaffold, Percutaneous Transluminal Angioplasty (PTA) Device
REVA Medical, Inc.
Critical Limb Ischemia
09/25
03/29
PRAEVA-2-LP, NCT05920317: Comparison of a Full Automatic Software With Standard Methods of Vessels Analysis

Recruiting
N/A
50
Europe
Nurea, Universitätsklinikum Leipzig
Abdominal Aortic Aneurysm
11/23
12/23
NCT05653336: PerQseal® Clinical Study

Active, not recruiting
N/A
149
Europe, US
PerQseal® Closure Device System
Vivasure Medical Limited
Percutaneous Large Hole Vascular Closure
12/24
06/25
NCT03982940: BGP+ Stent as Bridging Stent in BEVAR

Active, not recruiting
N/A
118
Europe
BGP+ Stent Graft System as bridging stent
Dr. Sabrina Overhagen, Bentley InnoMed GmbH
Thoracoabdominal Aortic Aneurysm, Without Mention of Rupture
05/24
07/25
ADVANCE, NCT05378347: Endurant Stent Graft System vs Excluder Endoprothesis: Trial

Recruiting
N/A
550
Europe, Japan, US, RoW
Medtronic Endurant II or Endurant IIs Stent Graft System, Gore Excluder or Gore/ Excluder Conformable AAA Endoprosthesis
Medtronic Cardiovascular
Abdominal Aortic Aneurysm, Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder), Abdominal Aortic Aneurysm >= 5.0 Centimeters in Female (Disorder)
05/27
05/31
DEFIANCE, NCT05701917: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis

Recruiting
N/A
300
Europe, US
ClotTriever System, Commercially available/market approved anticoagulation medication including but not limited to: Heparin Sodium, Coumadin, Rivaroxaban, Apixaban, etc.
Inari Medical
Venous Thromboembolism, Deep Venous Thrombosis, Post-Thrombotic Syndrome
06/25
10/25
NCT04393389: Acotec DCB Post Market Clinical Follow-up

Recruiting
N/A
3000
Europe
AcoArt Orchid (0.035"), AcoArt Tulip (0.018") and AcoArt Litos (0.014") percutaneous transluminal angioplasty (PTA) paclitaxel drug coated balloon catheter manufactured by Acotec Scientific Co., Ltd.
Acotec Scientific Co., Ltd
Peripheral Artery Disease
12/25
03/27
CRACK-IT, NCT06112171: Comparison of a Lithotripsy vs Standard Preparation Followed by Stenting With Supera Stent in Femoropopliteal Lesions

Recruiting
N/A
120
Europe
Intravascular lithotripsy, Standard lesion preparation
University of Leipzig
Peripheral Arterial Disease
11/26
12/30
ILICO, NCT05192616: Safety and Effectiveness Evaluation of iCover Covered Stent for the Treatment of the Aorto-iliac Occlusive Disease

Not yet recruiting
N/A
214
Europe
Covered stent implantation
iVascular S.L.U.
Angioplasty, Peripheral Arterial Disease, Iliac Artery Disease, Covered Stent, Aorto-Iliac Atherosclerosis
05/24
05/25
Ziemssen, Focke
CoRaLa II, NCT04444492: Combination of Ranibizumab and Targeted Laser Photocoagulation

Recruiting
3
110
Europe
Ranibizumab Injection, Lucentis, Laser photocoagulation
University of Giessen, University of Leipzig
Central Retinal Vein Occlusion With Macular Edema
07/25
07/25
EyeMatics, NCT06810011: Eye Diseases "Treated" with Interoperable Medical Informatics

Recruiting
N/A
2000
Europe
University Hospital Muenster, University Medicine Greifswald, University Medical Center Mainz, University Hospital, Aachen, Klinikum Chemnitz gGmbH, Technische Universität Dresden, University of Leipzig, University Hospital Tuebingen, Deutsche Ophthalmologische Gesellschaft e.V., Pro Retina Deutschland e.V.
Intravitreal Injections
02/28
02/28
Claßen, Joseph
Boss-Stroke, NCT05600374: Brain-Oscillation-Synchronized Stimulation to Enhance Motor Recovery in Early Subacute Stroke

Recruiting
N/A
144
Europe
Bossdevice
University Hospital Tuebingen
Ischemic Stroke, Acute
05/25
02/26
Günther, René
NfL-ALS, NCT06201650: Neurofilament Light Chain in Amyotrophic Lateral Sclerosis

Recruiting
N/A
3000
Europe
Neurofilament light chain
Charite University, Berlin, Germany, Boris Canessa ALS Stiftung
Amyotrophic Lateral Sclerosis, Motor Neuron Disease
12/24
12/24
NCT06418646: Patients' and Caregivers' Views of Multidimensional Care in Amyotropic Lateral Sclerosis in Germany

Recruiting
N/A
500
Europe
Technische Universität Dresden, ALS Association, German Society of Muscle Diseases
Amyotrophic Lateral Sclerosis
12/24
06/25
LIPCAL-ALS II, NCT06280079: Ultra-high-caloric, Fatty Diet in ALS

Recruiting
N/A
392
Europe
Ultra-high-caloric fatty diet, Placebo
University of Ulm
Amyotrophic Lateral Sclerosis
06/27
06/27
Konert, Manuela
DEFIANCE, NCT05701917: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis

Recruiting
N/A
300
Europe, US
ClotTriever System, Commercially available/market approved anticoagulation medication including but not limited to: Heparin Sodium, Coumadin, Rivaroxaban, Apixaban, etc.
Inari Medical
Venous Thromboembolism, Deep Venous Thrombosis, Post-Thrombotic Syndrome
06/25
10/25
Scheurig-Münkler, Christian
DEFIANCE, NCT05701917: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis

Recruiting
N/A
300
Europe, US
ClotTriever System, Commercially available/market approved anticoagulation medication including but not limited to: Heparin Sodium, Coumadin, Rivaroxaban, Apixaban, etc.
Inari Medical
Venous Thromboembolism, Deep Venous Thrombosis, Post-Thrombotic Syndrome
06/25
10/25

Download Options